Crescent Capital BDC Hits New 52-Week Low at $12.70

Crescent Capital BDC, Inc., a microcap company in the capital markets sector, has reached a new 52-week low of USD 12.70 as of February 25, 2026. This decline marks a significant downturn for the stock, which has experienced a 30.19% decrease over the past year, contrasting sharply with the S&P 500's performance of 12.95% during the same period. The company's financial metrics reveal a challenging landscape, with a price-to-earnings ratio of 12.00 and a notable dividend yield of 14.53%. However, Crescent Capital has faced difficulties, including a 10.11% drop in net sales and consecutive quarters of negative results. The most recent quarterly net sales were reported at USD 36.45 million, reflecting a decline of 16.72%. Additionally, the return on equity stands at 5.04%, while the price-to-book ratio is at 0.69. Crescent Capital's stock has consistently underperformed against market benchmarks, generating negative returns over the last three years. The stock's 52-week high was recorded at USD 18.57, highlighting the extent of its recent decline.